Skip to content
Exits and Outcomes
Sign In
Subscribe
Digital health research, news, and analysis from Brian Dolan.
Prescription Digital Therapeutics
All Newsletters
224 articles
22 of 23
Trouble in Pear-adise? More details on ESI’s digital formulary.
9.27.19
8
min. Read
Excerpts from the Pear Therapeutics Report.
9.13.19
2
min. Read
Novartis predicts Amazon DTx delivery. VR pain relief.
8.22.19
5
min. Read
Samsung’s quiet CardioBand FDA clearance. HealthXL’s evidence report.
8.08.19
4
min. Read
CPT vs drug reimbursement pathways. Cancer DTx enforcement discretion.
8.01.19
5
min. Read
The case against Proteus-Otsuka’s digital med. AliveCor’s 6th CEO
7.25.19
4
min. Read
FDA Pre-Cert tested with Pear insomnia DTx.
7.18.19
7
min. Read
Germany passes DTx formulary, payment law. Outcomes over Exits?
7.11.19
6
min. Read
Digital health formulary wars heat up. $40M price tag for a digital drug.
6.20.19
7
min. Read
Express Scripts talks but CVS launches. India’s 4,800 health startups.
6.13.19
4
min. Read
1 of 23